Motexafin Gadolinium Injection

DRUG5 trials

Sponsors

Pharmacyclics LLC.

Conditions

AstrocytomaBrain NeoplasmBreast NeoplasmsCarcinoma, BronchogenicGlioblastomaGliomaHead and Neck CancerHypopharynx Cancer

Phase 1

Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors

CompletedNCT00080041

Pharmacyclics LLC.Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms +1

Target: 20Updated: 2007-05-15

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

TerminatedNCT00080028

Pharmacyclics LLC.Head and Neck Cancer, Hypopharynx Cancer, Larynx Cancer +1

Target: 18Updated: 2007-05-08

A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

CompletedNCT00080054

Pharmacyclics LLC.Astrocytoma, Brain Neoplasm, Glioblastoma +2

Target: 24Updated: 2009-04-03

A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)

CompletedNCT00102505

Pharmacyclics LLC.Carcinoma, Bronchogenic, Non-Small-Cell Lung Carcinoma

Start: 2004-11-30Target: 36Updated: 2009-04-03

Phase 2

A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma

CompletedNCT00096837

Pharmacyclics LLC.Multiple Myeloma

Target: 25Updated: 2006-06-08